Various preclinical and clinical trials have been conducted the efficacy of celastrol. In data presented in the current manuscript is the first trial to inhibit Helicobacter pylori with celastrol. In this study, the quantitative change of various H. pylori proteins including CagA and VacA by the anti-bacterial effect of celastrol was determined. The anti-H. pylori effects of celastrol was investigated by performing 2-dimensional electrophoresis and additional supporting experiments. After 2-dimensional electrophoresis analysis, spot intensities were analyzed and then each spot was identified using matrix assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF-MS) or peptide sequencing using Finnigan LCQ ion trap mass spectrometer (LC-MS/MS). The results show that celastrol has multiple effects on protein expression in H. pylori.
Recently, interest in celastrol has renewed again as a new candidate drug for obesity and various chronic diseases (Cascao et al., 2017) . Celastrol has been reported primarily to exhibit inhibitory effects on several cancers, such as breast cancer, prostate cancer and colorectal cancer (Shrivastava et al., 2015; Guo et al., 2015; Lin et al., 2016) . And other preclinical and clinical trials on various purpose with celastrol have been continued till now (Fig. 1) . This is the first trial to inhibit Helicobacter pylori with celastrol. Here we demonstrated the preliminary clues for showing anti-H. pylori effects of celastrol by performing 2-dimensional electrophoresis and some supporting experiments. To suggest celastrol as a potential cure drug for H. pylori infection, we tried to find the relationship between the quantitative expression level changes of human gastrointestinal disease-responsible proteins. In our data, the expression levels of some virulence factors were inhibited, while some other factors which were related to bacterial cell survival were increased as 'compensatory hyperincrease'.
In H. pylori, cytotoxin-associated protein A (CagA) and vacuolating cytotoxic protein A (VacA) have been reported as the most representative virulence factors because they are responsible for gastric or duodenal cancer development directly (Censini et al., 1996; Cover et al., 1993 (Fig. 2) .
To perform the proteomics study, the harvested samples were suspended in 0.5 ml of 50 mM Tris buffer containing To identify the results, tryptic peptides were separated and analyzed using reversed phase capillary HPLC directly coupled to a Finnigan LCQ ion trap mass spectrometer (LC-MS/MS). For tandem mass spectrometry, a full mass scan range mode was m/z = 450~2,000 Da. The individual spectra from MS/MS were processed using the TurboSEQUEST software (Thermo Quest, San Jose, CA). The generated peak list files were used to query either MSDB database or NCBI using the MASCOT program (http://www.matrixscience.com).
Only significant hits as defined by MASCOT probability analysis were considered initially. methodologically the selected each protein spot was relatively evident than others in the 2-DE images and were identified by peptide mass fingerprinting using MALDI-TOF-MS or by peptide sequencing using LC-MS/MS (Table   1 , 2). All the analyzed 2-DE spot profiles of H. pylori 60190 strain among total spot profiles of protein changes were compared to reference data (Choi et al., 2002; Jungblut et al., 2000) . The displayed protein spots in this study were focused on the relation with clinical diseases, such as chronic gastritis, gastric ulcers, or gastric adenocarcinoma (Park et al., 2006; Backert et al., 2005) .
We could find meaningful nine protein spots which the expression level was decreased by celastrol treatment. They were preprotein translocase subunit SecA (SecA), U\urease subunit beta (UreB), flagellar basal body protein FliL (FliL), heat shock protein 90 (Hsp90), aconitate hydratase AcnB (AcnB), acylamide amidohydrolase (AmiE), 2-oxoglutarateacceptor oxidoreductase subunit (OorA), iron-dependent superoxide dismutase (SodB), and non-heme iron-containing ferritin (FtnA) (Fig. 3 and 4 ).
SecA; Sec-related proteins are associated with the type V secretion system (T5SS) of H. pylori (Cover and Blanke, 2005) . It has been reported that VacA secretion is SecAdependent (Cover and Blanke, 2005; Shaffer et al., 2011) .
This suggests that the decreased SecA expression might affect the accumulation of VacA in cell. We could also find such a phenomenon in our data ( Fig. 3 and 4 ).
UreB; Urease subunit beta with subunit alpha involve in critical role of H. pylori colonizing in acidic gastric environment (Park et al., 2006) . It has been reported that H. pylori ureases produces alkaline ammonia by degrading urea. H.
pylori can survive in acidic gastric environment thereby neutralizing acidic gastric environment with this alkaline substance. If the expression level of UreB was decreased by celastrol treatment, it showed that celastrol might be a potential inhibitor for H. pylori ( Fig. 3 and 4 ).
FliL; although the function of FliL in H. pylori is not clear yet, it has been reported that FliL is essential for swarming but not for swimming or motility in genus Proteus (Lee et al., 2013) . It is thought that H. pylori FliL is also a transmembrane protein located adjacent to the basal body of its flagellar structure (Lee and Belas, 2015) . When H. pylori was exposed to celastrol if the expression of FliL was decreased, it might be an expected positive result ( Fig. 3 and 4) . Hsp90; H. pylori Hsp90 showed decrease in its expression with celastrol in our data ( Fig. 3 and 4 ), although its function in H. pylori is not known yet.
AcnB, AmiE, OorA, SodB and FtnA; these molecules are important metabolic components in H. pylori. Thus, it was thought that the growth of H. pylori might be suppressed thereby inducing metabolic malfunction in H. pylori by celastrol treatment (Fig. 3 and 4 ).
Some other six proteins which are related to cell survival or pathogenicity were showed increased as irony. Because the celastrol was treated to H. pylori culture under the minimum inhibitory concentration (3 μM), it was thought that bacterial cells might fight for survival when they were exposed to celastrol. Here we explained this as 'compensatory hyperincrease'.
Cytotoxin-associated gene protein A (CagA), Vacuolating cytotoxic protein A (VacA), UreB, AmiE, OorA, and Heatshock protein 60 subunit (GroEL) were showed increased CagA and VacA; they toxin-like proteins of H. pylori are strongly responsible for significantly increased risk of the development of gastric disorders like chronic gastric inflammation, ulcers, various cancers (Censini et al., 1996) .
Although CagA accumulation in cell could not be explained in the aspect of its mechanism, here, in our data, VacA accumulation in cell could be explained readily. Because
VacA secretion is regulated by SecA-dependent T5 a SS, as shown prior, if SecA was decreased by exposing celastrol, its accumulation in cell would be induced (Kim et al., 2014) ( Fig. 3 and 4) . Now, the complete genome sequences of H. pylori strains 26695 and J99 had been reported (Alm et al., 1999; Tomb et al., 1997) , however the information is imperfect. Thus it is thought that the additional genomic or proteome information like this should be accumulated for further research.
